Portfolio (Quarterly)
Guide ↗
Rosalind Advisors, Inc.
· CIK 0001622627| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 3,231,700.0 | $18.7M | 7.53% | +1.1M | +53.0% | $5.80 | +6.5% |
| 2 | FENC | FENNEC PHARMACEUTICALS INC | Healthcare | 2,908,201.0 | $17.9M | 7.19% | +295K | +11.3% | $6.15 | +60.3% |
| 3 | EYPT | EYEPOINT PHARMACEUTICALS INC | Healthcare | 1,036,737.0 | $13.4M | 5.37% | +347K | +50.2% | $12.89 | -0.5% |
| 4 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 3,214,766.0 | $13.3M | 5.33% | +609K | +23.4% | $4.13 | -1.6% |
| 5 | — | VERASTEM INC | — | 2,138,475.0 | $11.3M | 4.55% | +350K | +19.6% | $5.30 | — |
| 6 | — CALL | REPLIMUNE GROUP INC | — | 1,275,600.0 | $2.7M | 1.10% | +1.0M | +452.4% | $2.15 | — |
| 7 | — | BIOFRONTERA INC | — | 1,163,962.0 | $942K | 0.38% | +23K | +2.0% | $0.81 | — |
| 8 | — CALL | ARRIVENT BIOPHARMA INC | — | 108,900.0 | — | — | +1K | +0.9% | — | — |
| 9 | — CALL | UNIQURE NV | — | 295,800.0 | — | — | +196K | +195.8% | — | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%